Companies: 10,795·Total market cap: $144.5T
Advanced Biomed Inc. Common Stock

Advanced Biomed Inc. Common Stock

ADVBNASDAQHealthcare● Active
$3.94
$-0.23(-5.52%)
Market Cap$4263557
P/E Ratio—
52W High$20
52W Low$3.61
SEC Filings

Advanced Biomed Inc. Common Stock (ADVB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001941029 · ADVB · NASDAQ · as of Jun 8, 2026

Filing snapshot

88
Total Filings
DEF 14A
Latest Form
2026-06-04
Most Recent
2025
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001941029 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-10-08
Fiscal Year End
Oct 8, 2025
Accession No.
0001213900-25-097465
Primary Document
ea0257629-10k_advanced.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001941029 · Accession 0001213900-25-097465

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-05-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
DEF 14AProxy Statement
DEFINITIVE PROXY STATEMENT
2026-06-04
View
10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
View
8-KCurrent Report
CURRENT REPORT
2026-05-01
View
8-KCurrent Report
CURRENT REPORT
2026-04-14
View
8-KCurrent Report
CURRENT REPORT
2026-04-03
View
8-KCurrent Report
CURRENT REPORT
2026-03-30
View
8-KCurrent Report
CURRENT REPORT
2026-03-16
View
8-KCurrent Report
CURRENT REPORT
2026-02-26
View
10-QQuarterly Report
QUARTERLY REPORT
2026-02-13
View
8-K/ACurrent Report (Amended)
AMENDMENT NO. 1 TO FORM 8-K
2026-02-10
View
8-KCurrent Report
CURRENT REPORT
2026-02-02
View
8-KCurrent Report
CURRENT REPORT
2026-01-27
View
DEF 14CDEF 14C
DEFINITIVE INFORMATION STATEMENT
2026-01-23
View
8-KCurrent Report
CURRENT REPORT
2026-01-21
View
PRE 14CPRE 14C
PRELIMINARY INFORMATION STATEMENT
2026-01-12
View
Showing 1–15 of 88 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001941029  |  Exchange: NASDAQ · Healthcare

Advanced Biomed Inc. Common Stock (NASDAQ: ADVB) has submitted 88 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Healthcare sector company with CIK 0001941029, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Advanced Biomed Inc. Common Stock's most comprehensive regulatory disclosure. The most recent Advanced Biomed Inc. Common Stock 10-K was filed on 2025-10-08 for fiscal year ending 2025. Historical ADVB 10-K annual reports are available from 2022 through 2025.

Investors researching Advanced Biomed Inc. Common Stock SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
MRKR SEC Filings →CHEK SEC Filings →APM SEC Filings →TRIB SEC Filings →MBIO SEC Filings →TNON SEC Filings →GELS SEC Filings →BGLC SEC Filings →
→ ADVB Financials→ ADVB Earnings→ ADVB Insider Trades

Frequently Asked Questions

ADVB SEC Filings · 8 questions

Advanced Biomed Inc. Common Stock (ADVB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 88 filings and access original documents at no cost. Advanced Biomed Inc. Common Stock's CIK is 0001941029.

ADVB SEC filingsAdvanced Biomed Inc. Common Stock SEC documentsfind ADVB 10-K